Literature DB >> 31256051

Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis.

Christina DiMaria1, Wael Hanna2, Julie Murone3, James Reichart2.   

Abstract

Direct oral anticoagulants (DOACs)-dabigatran, rivaroxaban, apixaban and edoxaban-are changing the landscape of clinical practice for patients requiring short and long-term anticoagulation. We report a patient with no history of kidney disease developing acute interstitial nephritis (AIN) after starting a DOAC, apixaban. To date, this is the first biopsy proven case of apixaban-induced AIN. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute renal failure; haematology (drugs and medicines); haematology (incl blood transfusion); renal system

Mesh：

Substances：

Year:  2019        PMID： 31256051      PMCID： PMC6605927          DOI： 10.1136/bcr-2019-230371

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  11 in total

1.  The outcome of acute interstitial nephritis: risk factors for the transition from acute to chronic interstitial nephritis.

Authors:  A Schwarz; P H Krause; U Kunzendorf; F Keller; A Distler
Journal:  Clin Nephrol       Date:  2000-09       Impact factor: 0.975

2.  Incidence of latent mesangial IgA deposition in renal allograft donors in Japan.

Authors:  Koichi Suzuki; Kazuho Honda; Kazunari Tanabe; Hiroshi Toma; Hiroshi Nihei; Yutaka Yamaguchi
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

3.  Novel oral anticoagulant and kidney injury: apixaban-related acute interstitial nephritis.

Authors:  Basma Abdulhadi; Ramzi Mulki; Abhinav Goyal; Janani Rangaswami
Journal:  BMJ Case Rep       Date:  2017-08-28

4.  National Trends in Ambulatory Oral Anticoagulant Use.

Authors:  Geoffrey D Barnes; Eleanor Lucas; G Caleb Alexander; Zachary D Goldberger
Journal:  Am J Med       Date:  2015-07-02       Impact factor: 4.965

Review 5.  Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation.

Authors:  Freddy Del-Carpio Munoz; S Michael Gharacholou; Thomas M Munger; Paul A Friedman; Samuel J Asirvatham; Douglas L Packer; Peter A Noseworthy
Journal:  Am J Cardiol       Date:  2015-10-21       Impact factor: 2.778

6.  Rivaroxaban-related acute kidney injury in a patient with IgA vasculitis.

Authors:  Yoshihiko Fujino; Chisato Takahashi; Kensuke Mitsumoto; Takashi Uzu
Journal:  BMJ Case Rep       Date:  2019-01-29

Review 7.  New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events.

Authors:  Ymer H Mekaj; Agon Y Mekaj; Shkelzen B Duci; Ermira I Miftari
Journal:  Ther Clin Risk Manag       Date:  2015-06-24       Impact factor: 2.423

8.  Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy.

Authors:  Sergey V Brodsky; Nilesh S Mhaskar; Sampath Thiruveedi; Rajnish Dhingra; Sharon C Reuben; Edward Calomeni; Iouri Ivanov; Anjali Satoskar; Jessica Hemminger; Gyongyi Nadasdy; Lee Hebert; Brad Rovin; Tibor Nadasdy
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

9.  Dabigatran-Induced Acute Interstitial Nephritis: An Important Complication of Newer Oral Anticoagulation Agents.

Authors:  Swapnil Patel; Mohammad A Hossain; Firas Ajam; Mayurkumar Patel; Mihir Nakrani; Jasmine Patel; Alsadiq Alhillan; Mohamed Hammoda; Anas Alrefaee; Michael Levitt; Arif Asif
Journal:  J Clin Med Res       Date:  2018-09-10

Review 10.  Anticoagulants and acute kidney injury: clinical and pathology considerations.

Authors:  Sergey V Brodsky
Journal:  Kidney Res Clin Pract       Date:  2014-11-18
View more
  4 in total

1.  The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.

Authors:  Ziv Harel; Eric McArthur; Nivethika Jeyakumar; Manish M Sood; Amit X Garg; Samuel A Silver; Paul Dorian; Daniel Blum; William Beaubien-Souligny; Andrew T Yan; Sunil V Badve; Brendan Smyth; Min Jun; Racquel Jandoc; Abhijat Kitchlu; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2021-08-18       Impact factor: 10.614

2.  Dabigatran-Induced Nephropathy and Gastrointestinal Bleeding and Its Successful Treatment with Idarucizumab: A Case Report.

Authors:  Francesca Marchesini; Andrea Ossato; Alberto Zendrini; Federica Arginelli; Teresa Zuppini; Nicola Realdon; Massimo Zamperini; Roberto Tessari
Journal:  Hosp Pharm       Date:  2021-05-22

3.  Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use.

Authors:  Zhen-Ling Deng; Wen-Ling Yang; Xin-Yue Zhao; Zi-Yong Tang; Dan-Xia Zheng; Yue Wang
Journal:  Ren Fail       Date:  2022-01-27       Impact factor: 3.222

4.  The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients.

Authors:  Wei-Chieh Lee; Pai-Wei Lee; Po-Jui Wu; Yen-Nan Fang; Huang-Chung Chen; Yu-Sheng Lin; Hsiu-Yu Fang; Shang-Hung Chang; Ping-Yen Liu; Mien-Cheng Chen
Journal:  Thromb J       Date:  2021-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.